Basic Fibroblast Growth Factor Expression in Endothelial Cells: An Autocrine Role in Angiogenesis?
bFGF belongs to the family of the heparin-binding growth factors (Basilico and Moscatelli, 1992). The single copy human bFGF gene encodes multiple bFGF isoforms with molecular weights ranging from 24 kD to 18 kD. High molecular weight isoforms (HMW-bFGFs) are colinear NH2-terminal extensions of the better characterized 18 kD protein (Florkiewicz and Sommer, 1989). Both low and high molecular weight bFGFs exert angiogenic activity in vivo and induce cell proliferation, protease production, and Chemotaxis in cultured endothelial cells (Gualandris et al., 1994). Also, bFGF has been shown to stimulate endothelial cells to form capillary-like structures in collagen gels (Montesano et al., 1986) and to invade the amniotic membrane in vitro (Mignatti et al, 1989). The phenotype induced in vitro by bFGF in endothelial cells includes also modulation of integrin expression (Klein et al., 1993), gap-junctional intercellular communication (Pepper and Meda, 1992) and urokinase receptor upregulation (Mignatti et al., 1991). Experiments performed with neutralizing anti-bFGF antibodies have implicated endogenous bFGF in wound repair (Broadley et al., 1989), vascularization of the chorioallantoic membrane during chick embryo development (Ribatti et al., 1995), and tumor growth (Baird et al., 1986; Gross et al., 1993).
KeywordsHeparin Sarcoma Gelatin Thrombin Meningioma
Unable to display preview. Download preview PDF.
- Broadly K.N., A.M. Aquino, S.C. Woodward, A. Buckley-Sturrock, Y. Sato, D.B. Rifkin, and J.M. Davidson. 1989. Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab. Invest. 61:571–575.Google Scholar
- Cozzolino, F., M. Torcia, M. Lucibello, L. Morbidelli, M. Ziehe, J. Platt, S. Fabiani, J. Brett, and D. Stern. 1993. Cytokine-mediated control of endothelial cell growth: interferon-α and interleukin-2 synergistically enhance basic fibroblast growth factor synthesis and induce release promoting cell growth in vitro and in vivo. J. Clin. Invest. 91:2504–2512.CrossRefGoogle Scholar
- Enzinger, F.M., and Weiss, S.W. 1995. Soft tissue tumors. Mosby-Year Book, Inc. St. Louis, pp.658–669.Google Scholar
- Good, D.J., P.J. Polverini, F. Rastinejad, M.M. LeBeau, R.S. Lemons, W.A. Frazier, and N.P. Bouck. 1990. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA. 87:6624–6628.PubMedCrossRefGoogle Scholar
- Gualandris, A., D. Coltrini, L. Bergonzoni, A. Isacchi, S. Tenca, B. Ginelli, and M. Presta. 1993. The NH2-terminal extension of high molecular weight forms of basic fibroblast growth factor (bFGF) is not essential for the binding of bFGF to nuclear chromatin in transfected NIH 3T3 cells. Growth Factors. 8:49–60.PubMedCrossRefGoogle Scholar
- Gualandris, A., C. Urbinati, M. Rusnati, M. Ziehe, and M. Presta. 1994. Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: biological activity and intracellular fate of human recombinant Mr 24,000 bFGF. J. Cell. Physiol. 161:149–159.PubMedCrossRefGoogle Scholar
- Passaniti, A., R.M. Taylor, R. Pili, Y. Guo, P.V. Long, J.A. Haney, R.R. Pauly, D.S. Grant, and G.R. Martin. 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67:519–528.PubMedGoogle Scholar
- Peverali, F.A., S.J. Mandriota, P. Ciana, R. Marelli, P. Quax, D.B. Rifkin, G. Delia Valle, and P. Mignatti. 1994. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells. J. Cell. Physiol. 161:1–14.PubMedCrossRefGoogle Scholar
- Ribatti, D., C. Urbinati, B. Nico, M. Rusnati, L. Roncali, and M. Presta. 1995. Endogenous basic fibroblast growth factor in the vascularization of the chick embryo chorioallantoic membrane. Dev. Biol., in press.Google Scholar
- Schanper, H.W., D.S. Grant, W.G. Stetler-Stevenson, R. Fridman, G. D’Orazi, A.N. Murphy, R.E. Bird, M. Hoythya, T.R. Fuerst, D.L. French, J.P. Quigley, and H.K. Kleinman. 1993. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156:235–246CrossRefGoogle Scholar
- Takahashi, J.A., H. Mori, M. Fukumoto, K. Igarashi, M. Jaye, Y. Oda, H. Kikuchi, and M. Hatanaka. 1990. Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc. Natl. Acad. Sci. U.S.A.87:5710–5714.PubMedCrossRefGoogle Scholar
- Ziehe, M., G. Alessandri, and P.M. Gullino. 1989. Gangliosides promote the angiogenic response. Lab. Invest. 61:629–634.Google Scholar